{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:11:44Z","timestamp":1790266304755,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cardiacep.theclinics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiac Electrophysiology Clinics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ccep.2024.10.001","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T21:17:08Z","timestamp":1731705428000},"page":"13-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Atrial Fibrillation-Induced Cardiomyopathy"],"prefix":"10.1016","volume":"17","author":[{"given":"Fengwei","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghamitra","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Natale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Di Biase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ccep.2024.10.001_bib1","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.ccep.2024.10.001_bib2","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/CIRCULATIONAHA.117.031431","article-title":"Genetic predis- position, clinical risk factor burden, and lifetime risk of atrial fibrillation","volume":"137","author":"Weng","year":"2018","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.ccep.2024.10.001_bib3","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1161\/CIRCULATIONAHA.117.028981","article-title":"Sex dif- ferences and similarities in atrial fibrillation epidemi- ology, risk factors, and mortality in community cohorts: results from the BiomarCaRE consortium (biomarker for cardiovascular risk assessment in Eu- rope)","volume":"136","author":"Magnussen","year":"2017","journal-title":"Circulation"},{"issue":"9989","key":"10.1016\/j.ccep.2024.10.001_bib4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.ccep.2024.10.001_bib5","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","article-title":"Life-time risk for developing congestive heart failure: the Framingham Heart Study","volume":"106","author":"Lloyd-Jones","year":"2002","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ccep.2024.10.001_bib6","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/eurjhf\/hfr066","article-title":"Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction","volume":"13","author":"Linssen","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.ccep.2024.10.001_bib7","doi-asserted-by":"crossref","first-page":"e005694","DOI":"10.1161\/JAHA.112.005694","article-title":"Atrial fibrilla- tion and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction","volume":"2","author":"McManus","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"18","key":"10.1016\/j.ccep.2024.10.001_bib8","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1001\/jama.296.18.2209","article-title":"Systolic and diastolic heart failure in the community","volume":"296","author":"Bursi","year":"2006","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.ccep.2024.10.001_bib9","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ehj.2004.06.006","article-title":"Differences between patients with a pre- served and a depressed left ventricular function: a report from the EuroHeart Failure Survey","volume":"25","author":"Lenzen","year":"2004","journal-title":"Eur Heart J"},{"issue":"6A","key":"10.1016\/j.ccep.2024.10.001_bib10","doi-asserted-by":"crossref","first-page":"2D","DOI":"10.1016\/S0002-9149(02)03373-8","article-title":"Atrial fibrillation in heart failure: epidemiology, pathophysiology, and ratio- nale for therapy","volume":"91","author":"Maisel","year":"2003","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ccep.2024.10.001_bib11","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9343(99)80348-9","article-title":"The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study","volume":"98","author":"Krahn","year":"1995","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.ccep.2024.10.001_bib12","doi-asserted-by":"crossref","first-page":"e000102","DOI":"10.1161\/JAHA.112.000102","article-title":"Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium","volume":"2","author":"Alonso","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ccep.2024.10.001_bib13","doi-asserted-by":"crossref","first-page":"i4482","DOI":"10.1136\/bmj.i4482","article-title":"Atrial fibrilla- tion and risks of cardiovascular disease, renal dis- ease, and death: systematic review and meta- analysis","volume":"354","author":"Odutayo","year":"2016","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ccep.2024.10.001_bib14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.hrthm.2017.01.031","article-title":"No decline in the risk of heart failure after incident atrial fibrillation: a community study assessing trends overall and by ejection fraction","volume":"14","author":"Chamberlain","year":"2017","journal-title":"Heart Rhythm"},{"issue":"8","key":"10.1016\/j.ccep.2024.10.001_bib15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jchf.2017.05.001","article-title":"Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"5","author":"Sartipy","year":"2017","journal-title":"JACC Heart Fail"},{"issue":"23","key":"10.1016\/j.ccep.2024.10.001_bib16","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal rela- tions of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framing- ham Heart Study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccep.2024.10.001_bib17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.CIR.85.2.717","article-title":"Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy","volume":"85","author":"Spinale","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2024.10.001_bib18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0735-1097(96)00592-X","article-title":"Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies","volume":"29","author":"Shinbane","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ccep.2024.10.001_bib19","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/01.RES.69.4.1058","article-title":"Relation between ventricular and myocyte remodeling with the development and regression of supraventricular tachycardia-induced cardiomyopathy","volume":"69","author":"Spinale","year":"1991","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.ccep.2024.10.001_bib20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/CIRCEP.113.000681","article-title":"Diffuse ventricular fibrosis is a late outcome of tachycardia-mediated cardiomyopathy after successful ablation","volume":"6","author":"Ling","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"35","key":"10.1016\/j.ccep.2024.10.001_bib21","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1093\/eurheartj\/ehad396","article-title":"Histological validation of atrial structural remodelling in patients with atrial fibrillation","volume":"44","author":"Takahashi","year":"2023","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ccep.2024.10.001_bib22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1161\/CIRCHEARTFAILURE.112.968321","article-title":"Irregular rhythm adversely influences calcium handling in ventricular myocardium: implications for the interaction between heart failure and atrial fibrillation","volume":"5","author":"Ling","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"7","key":"10.1016\/j.ccep.2024.10.001_bib23","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/CIRCULATIONAHA.106.636845","article-title":"Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation","volume":"114","author":"El-Armouche","year":"2006","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ccep.2024.10.001_bib24","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.123.066577","article-title":"Impaired intracellular calcium buffering contributes to the arrhythmogenic substrate in atrial myocytes from patients with atrial fibrillation","volume":"150","author":"Fakuade","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ccep.2024.10.001_bib25","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2009.05.015","article-title":"The sympa- thetic nervous system in heart failure physiology, pathophysiology, and clinical implications","volume":"54","author":"Triposkiadis","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ccep.2024.10.001_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0022-3565(25)32412-2","article-title":"Beta-1 receptor mediation of renin secretion elicited by low-frequency renal nerve stimulation","volume":"216","author":"Osborn","year":"1981","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.ccep.2024.10.001_bib27","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1161\/01.CIR.0000064900.76674.CC","article-title":"Effect of atrial fibrillation and an irregular ventricular response on sympathetic nerve activity in human subjects","volume":"107","author":"Wasmund","year":"2003","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ccep.2024.10.001_bib28","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/CIRCRESAHA.121.319718","article-title":"Effects of atrial fibrillation on the human ventricle","volume":"130","author":"Pabel","year":"2022","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.ccep.2024.10.001_bib29","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0735-1097(01)01596-0","article-title":"Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy","volume":"38","author":"Shite","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccep.2024.10.001_bib30","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.ijcard.2012.03.118","article-title":"Documentation of impaired coronary blood flow by TIMI frame count method in patients with atrial fibrillation","volume":"167","author":"Luo","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ccep.2024.10.001_bib31","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/eurheartj\/ehm246","article-title":"Impaired myocardial perfusion and perfusion reserve asso- ciated with increased coronary resistance in persistent idiopathic atrial fibrillation","volume":"28","author":"Range","year":"2007","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ccep.2024.10.001_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0022-2828(92)93165-G","article-title":"Myocardial Na+,K(+)-ATPase in tachycardia induced cardiomyopathy","volume":"24","author":"Spinale","year":"1992","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"17","key":"10.1016\/j.ccep.2024.10.001_bib33","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jacc.2017.02.049","article-title":"Histopathological and immunological characteristics of tachycardia-induced cardiomyopathy","volume":"69","author":"Mueller","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1 Pt 2","key":"10.1016\/j.ccep.2024.10.001_bib34","first-page":"H218","article-title":"Chronic supraventricular tachycardia causes ventricular dysfunction and subendocardial injury in swine","volume":"259","author":"Spinale","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ccep.2024.10.001_bib35","doi-asserted-by":"crossref","first-page":"3339s","DOI":"10.1093\/eurheartj\/ehad396","article-title":"Histo- logical validation of atrial structural remodelling in patients with atrial fibrillation","volume":"44","author":"Takahashi","year":"2023","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ccep.2024.10.001_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/CIRCEP.113.000689","article-title":"Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI","volume":"7","author":"McGann","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"10.1016\/j.ccep.2024.10.001_bib37","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jama.2014.3","article-title":"Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study","volume":"311","author":"Marrouche","year":"2014","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.ccep.2024.10.001_bib38","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jacc.2017.08.041","article-title":"Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study","volume":"70","author":"Prabhu","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccep.2024.10.001_bib39","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.ccep.2024.10.001_bib40","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJMoa2306037","article-title":"Catheter ablation in end-stage heart failure with atrial fibrillation","volume":"389","author":"Sohns","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccep.2024.10.001_bib41","doi-asserted-by":"crossref","first-page":"euae121","DOI":"10.1093\/europace\/euae121","article-title":"Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trial","volume":"26","author":"Rillig","year":"2024","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.ccep.2024.10.001_bib42","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.CIR.92.3.562","article-title":"Angiotensin-converting enzyme inhibition and the progression of congestive cardiomyopathy. Effects on left ventricular and myocyte structure and function","volume":"92","author":"Spinale","year":"1995","journal-title":"Circulation"}],"container-title":["Cardiac Electrophysiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918224000583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918224000583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T13:45:43Z","timestamp":1749822343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877918224000583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1877918224000583"],"URL":"https:\/\/doi.org\/10.1016\/j.ccep.2024.10.001","relation":{},"ISSN":["1877-9182"],"issn-type":[{"value":"1877-9182","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial Fibrillation-Induced Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Cardiac Electrophysiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccep.2024.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}